Assembly Biosciences, Inc.
ASMBNASDAQHealthcare● Active
$23.60
+$1.04(+4.63%)
Market Cap$375056571
P/E Ratio—
52W High$39.71
52W Low$15.71
Assembly Biosciences, Inc. (ASMB) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ASMB · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $248.11M | $112.08M | $130.25M | $91.61M | $146.63M |
| Net Receivables | $0.97M | $0.40M | $0.04M | $0.94M | $0.34M |
| Inventory | $0.00M | $0.00M | ($3.20M) | $0.00M | $0.00M |
| Total Current Assets | $254.55M | $115.50M | $133.79M | $96.97M | $154.20M |
| PP&E Net | $2.73M | $3.35M | $2.72M | $3.94M | $7.18M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $257.59M | $119.17M | $136.82M | $101.79M | $191.06M |
| Liabilities | |||||
| Short-Term Debt | $0.57M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $1.17M | $0.58M | $0.46M | $2.49M | $2.66M |
| Total Current Liabilities | $48.78M | $47.80M | $39.23M | $16.30M | $16.07M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $50.84M | $85.81M | $95.73M | $19.13M | $22.13M |
| Stockholders Equity | |||||
| Retained Earnings | ($832.05M) | ($825.92M) | ($785.75M) | ($724.52M) | ($631.43M) |
| Total Stockholders Equity | $206.75M | $33.36M | $41.10M | $82.66M | $168.93M |
| Total Liab & Equity(computed) | $257.59M | $119.17M | $136.82M | $101.79M | $191.06M |
| Debt Summary | |||||
| Total Debt | $2.63M | $3.09M | $2.34M | $3.46M | $6.48M |
| Net Debt | ($55.82M) | ($35.26M) | ($17.50M) | ($48.95M) | ($39.15M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Assembly Biosciences, Inc. data
About Assembly Biosciences, Inc. (ASMB) Balance Sheet
Assembly Biosciences, Inc. (ASMB) balance sheet shows total assets of $0.26B with cash of $0.25B. Total liabilities are $0.05B, total debt $0.00B, and stockholders equity $0.21B.
Frequently asked questions
ASMB · 4 questionsAssembly Biosciences, Inc. has total debt of $0.00B with net debt of ($0.06B).
ASMB total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10